The substantial burden of central line-associated bloodstream infections (CLABSI) cannot be understated, given its significant impact on healthcare systems. These infections notably enhance morbidity and mortality risks while lengthening the duration of inpatient hospital stays and concurrently escalating the overall hospitalization cost. Quality improvement initiatives aimed at curbing the incidence of such infections are key and often involve the deployment, measurement, and subsequent monitoring of outcomes. However, the role of various details including geographical location, healthcare organizations’ operational differences, patient risk profiles, and the existing medical practice gaps, are critical to the success of such preventive strategies. The study reviewed herein was primarily focused on evaluating such interventions under the umbrella of a quality improvement project. The project aimed at reducing the rate of CLABSI is in a university teaching hospital setting.
Following the Plan-Do-Study-Act quality improvement cycle, the study utilized a retrospective review technique to evaluate an implemented quality improvement project. Active surveillance of both processes and outcomes was done in the critical care areas, specifically examining compliance to central line care bundles and incidences of CLABSI. Statistical tools, including interrupted time series and regression modeling, were used to evaluate trends and estimate data subsets before and after the intervention phase. During the analysis period, the study recorded 350 central line insertions, 3912 catheter days, and 20 identifiable CLABSI events. The compliance rate for the central line care bundles stands at an impressive 94%. However, the observed decreasing trend in CLABSI incidents by 18% did not meet statistical significance (p =0.252).
Efforts aimed at reducing central line-associated bloodstream infections involve complex steps, especially when implementing interventions in practical healthcare settings. The need for continued monitoring, assessment, and fine-tuning of interventions cannot be overstated in order to optimize healthcare outcomes. Furthermore, understanding patterns of non-adherence is essential in realizing the desired patient outcome. Lastly, of crucial importance is that central line-associated bloodstream infections, though common, are preventable. As such, initiatives driven towards combating these infections need sustained attention, strategy adaptation, and due diligence, considering the extensive use of central venous catheters, particularly in critical care units and the increasing number of CLABSI cases yearly, with the United States alone recording between 30,000 to 40,000 cases.
Source: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08744-5